1. Academic Validation
  2. Acidic solvent improves cisplatin action in in-vitro

Acidic solvent improves cisplatin action in in-vitro

  • Biochem Biophys Res Commun. 2024 Jun 18:712-713:149936. doi: 10.1016/j.bbrc.2024.149936.
Yuna Kim 1 Hyeong-Min Lee 2
Affiliations

Affiliations

  • 1 Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
  • 2 Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA. Electronic address: hlee1@stjude.org.
Abstract

As cisplatin is one of the most broadly used chemotherapeutics, it is widely tested in vitro & in vivo assays, involving attempts to better understand its mechanism of action, develop strategies to mitigate its toxicity, or develop new drug combinations. Presently, for in vitro assays, dissolving cisplatin in dimethyl sulfoxide (DMSO) is discouraged due to its significant reduction in drug activity, Alternatively, inorganic solvents like normal saline (NS) are recommended. However, this approach is still problematic, including 1) instability of cisplatin in NS, 2) limited solubility, 3) the need to avoid long-term storage at -80 °C (or -20 °C) after dissolving, and 4) complications when combining with other DMSO-solubilized compounds. Here, we report a DMSO-HCl mixture as an alternative solvent to address these challenges. Cisplatin in DMSO-HCl not only retains comparable drug activity to cisplatin in NS but also exhibits increased stability over an extended period. Our brief report sheds LIGHT on cisplatin action, providing insights to aid in Cancer research in vitro.

Figures
Products